🇬🇧 UK Biotech News - Latest Headlines

Verona Biotech, the London-based biotech company behind a breakthrough treatment for chronic obstructive pulmonary disease ...Continue Reading

July 7, 2025

Cambridge-based biotech firm has entered into a new partnership with a specialist venture fund to explore treatments for paralysis using artificial intelligence.Healx, which uses machine learning to discover ...Continue Reading

June 30, 2025

London-based life sciences startup, Portal Biotech has secured £27.5 million ($35 million) in Series A funding, led by the NATO Innovation Fund and London-based Hoxton Ventures. The company ...Continue Reading

June 25, 2025

The US Food and Drug Administration (FDA) has approved a new lung cancer treatment developed by AstraZeneca, the British–Swedish pharmaceutical group headquartered in Cambridge, and its Japanese partner ...Continue Reading

June 25, 2025

Cambridge-based startup OutSee has secured £1.8 million in seed funding to accelerate its use of artificial intelligence in genomics for drug discovery.The funding round was led by Ahren ...Continue Reading

June 24, 2025

The UK has launched a major open-science initiative, OpenBind, aimed at supporting the development of artificial intelligence in drug discovery. Based at the Diamond Light Source in Oxfordshire, ...Continue Reading

June 24, 2025

German biotech company BioNTech has confirmed a plan to invest up to £1 billion in the UK over the next decade, significantly expanding its R&D footprint with government ...Continue Reading

June 21, 2025

📍Cardiff - Draig Therapeutics has launched from stealth after raising $140 million (£107 million) in a Series A round. The Wales-based startup, spun out of Cardiff University’s Medicines ...Continue Reading

June 17, 2025

University of Exeter biotech spin-out is taking a bold step into the global longevity landscape. SENISCA, which emerged from nearly two decades of academic research at Exeter, will ...Continue Reading

June 10, 2025

The UK government has committed £86 billion to research and development over the next four years, with life sciences identified as a strategic priority. The funding, which averages ...Continue Reading

June 1, 2025

Regional leaders in Greater Manchester and Liverpool City Region are working together to propose a new initiative aimed at improving the UK’s biotech and life sciences infrastructure. Central ...Continue Reading

Latest Key Appointments

Read More
Maxion Therapeutics appoints Dr Stefan Härtle as CDO
Read More
Shift Bioscience Appoints Lord David Prior as Chair and Sir Tony Kouzarides as Scientific Advisor
Read More
Kate Woolland Appointed CEO of Closed Loop Medicine
Read More
Sphere Bio Appoints Dale Levitzke as CEO
Read More
ABPI appoints Russell Abberley as Acting President

Editor Picks 

Merck to Acquire London Based Verona Pharma in £7.8 Billion Deal
Healx partners with SCI Ventures on paralysis research
Portal Biotech secures £27.5 million NATO investment to counter bioengineered threats
AstraZeneca Lung Cancer ADC Approved by US Regulator
UK Biotech OutSee raises £1.8m to expand AI-driven drug discovery
UK Launches OpenBind to Advance AI-Driven Drug Discovery